Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 4Withdrawn 2Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 2Prostatic Neoplasms 1Pancreatic Adenocarcinoma Resectable 1Melanoma 1Cholangiocarcinoma 1Bile Duct Neoplasms 1

Interventions

Sorafenib 13Radiosurgery 9spartalizumab 7lenvatinib 7Oxaliplatin 6Gemcitabine 5Fluorouracil 5Radiotherapy 4Cisplatin 4Bevacizumab 4atezolizumab 3Leucovorin 3Folfox protocol 3Doxorubicin 3gadolinium ethoxybenzyl DTPA 2fludarabine 2cabozantinib 2Nivolumab 2Mitomycin 2Electroporation 2Cyclophosphamide 2Chemoembolization, Therapeutic 2tremelimumab 1toripalimab 1tocilizumab 1tislelizumab 1temsirolimus 1tazemetostat 1sitravatinib 1pirarubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma, Hepatocellular × Electroporation × Clear all
NCT04404647 2021-03-26

Irreversible Electroporation of Unresectable Liver Tumors

Aalborg University Hospital

Phase NA Withdrawn
Gastrointestinal

Bile Duct Neoplasms, Carcinoma, Hepatocellular

NCT03040453 2020-11-30

IRAL

Karolinska Institutet

Phase NA Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡